2023-10-23T09:44:09-05:00 2022-12-31 510232399 BELFINT LYONS & SHUMAN PA 1011 CENTRE RD STE 310 WILMINGTON DE 19805 990 2022-01-01 237076117 AMERICAN FRIENDS OF SHEBA MEDICAL CENTER INC AMER 3108380704 6505 WILSHIRE BLVD 615 LOS ANGELES CA 90048 DAVID PULVER BOARD CHAIR 3108380704 2023-10-03 1 DAVID PULVER 999009999 0 JONATHAN D MOLL CPA P01053700 3022250600 2023-10-03 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z DAVID PULVER 6505 WILSHIRE BLVD 615 LOS ANGELES CA 90048 27872381 0 X WWW.AFSMC.ORG X 1970 CA AFSMC RAISES FUNDS TO SUPPORT SHEBA MEDICAL CENTER, ONE OF THE TOP TEN HOSPITALS IN THE WORLD.THROUGHOUT THE YEARS, AMERICAN FRIENDS OF SHEBA MEDICAL CENTER HAS SHOWN INCREDIBLE DEDICATION TO THE INNOVATIVE AND INTEGRATED MEDICAL CARE THAT SHEBA MEDICAL CENTER PROVIDES TO EACH AND EVERY PATIENT. OUR PARTNERSHIP HELPS SHEBA TO DELIVER THE HIGHEST STANDARDS OF MEDICINE, RESEARCH, AND TECHNOLOGY BENEFITTING ISRAEL AND THE ENTIRE WORLD. 13 13 11 85 0 0 10942464 27671177 0 0 2353 1204 -47007 -361285 10897810 27311096 11737560 19236583 0 0 1232775 1676701 0 0 1072570 665846 1308565 13636181 22221849 -2738371 5089247 13090585 16881245 2219528 922132 10871057 15959113 X THROUGHOUT THE YEARS, AMERICAN FRIENDS OF SHEBA MEDICAL CENTER HAS SHOWN INCREDIBLE DEDICATION TO THE INNOVATIVE AND INTEGRATED MEDICAL CARE THAT SHEBA MEDICAL CENTER PROVIDES TO EACH AND EVERY PATIENT. OUR PARTNERSHIP HELPS SHEBA TO DELIVER THE HIGHEST STANDARDS OF MEDICINE, RESEARCH, AND TECHNOLOGY BENEFITTING ISRAEL AND THE ENTIRE WORLD. 0 0 20010845 19236583 1. AFSMC GIVEN $500K FOR THE UKRAINE FIELD HOSPITAL.IN RESPONSE TO THE WAR IN UKRAINE, ISRAEL MADE THE DECISION TO PUT A FIELD HOSPITAL INTO UKRAINE AND PUT SHEBA MEDICAL CENTER IN CHARGE OF IT. 2. $1.85M COMMITMENT FOR STEM CELL PROCESSING CENTER AND DNA/RNA CLINICAL UNITSHEBA RECEIVED A COMMITTMENT FROM A FOUNDATION THAT BEGAN GIVING HEAVILY TO MEDICAL CAUSES TO CONTRIBUTE $1.85M OVER TWO YEARS. $1,000,000 TOWARD SHEBA'S NATIONAL STEM CELL PROCESSING CENTER AND $865,000 TOWARD ESTABLISHING THE DNA AND RNA CLINICAL UNIT. BOTH OF THESE CONTRIBUTIONS WILL ALLOW SHEBA TO MAKE MEANINGFUL STEPS FORWARD IN THOSE AREAS.3. $11M IS CONTRIBUTED TOWARD THE NEW ONCOLOGY HOSPITALSHEBA IS A WORLD LEADER IN MANY ASPECTS OF CANCER TREATMENT. DR. TALIA GOLAN IS AN INTERNATIONALLY KNOWN NAME IN PANCREATIC CANCER AND THE BRCA MUTATION. SHEBA ALSO HAS BEEN A LEADER IN FREEZING CANCER CELLS IN BREAST AND PROSTATE CANCER, AMONG OTHER TREATMENTS. HOWEVER, THE CURRENT ONCOLOGY BUILDING IS NOT UP TO THE NEEDS OF THE PROGRAM AND PATIENTS AND THE MEDICAL CENTER IS ERECTIVE A MAJOR NEW BUILDING TO HOUSE ALL CANCER TREATMENT, RADIATION THERAPY, SCREENING, ETC. SHEBA SECURED FUNDING IN THE AMOUNT OF $11M IN 2022 TO HELP COVER THE COSTS. 20010845 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 1 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 32 0 1 11 1 0 0 0 0 0 0 0 0 0 0 0 0 X 13 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MN MS NV NH NJ NM NY NC OH OK OR PA RI SC TN UT VA WA WV WI MA MI X THE ORGANIZATION 3108380704 6505 WILSHIRE BLVD 615 LOS ANGELES CA 90048 DAVID PULVER BOARD CHAIR 1.00 X X 0 0 0 SHOSHANA DJAVAHERI-ZAR BOARD VICE -CHAIR 1.00 X X 0 0 0 MIRA BAR-MASHIAH TREASURER 1.00 X X 0 0 0 RUTH STEINBERGER SECRETARY 1.00 X X 0 0 0 YARIV BEN-ARI DIRECTOR 1.00 X 0 0 0 LUISA CANNELLA DIRECTOR 1.00 X 0 0 0 DAPHNA CRAMER DIRECTOR 1.00 X 0 0 0 ISHAIA GOL DIRECTOR 1.00 X 0 0 0 JERRY KATZ DIRECTOR 1.00 X 0 0 0 LILY SAAD DIRECTOR 1.00 X 0 0 0 STEVE HITTER DIRECTOR 1.00 X 0 0 0 STEVEN LAVIN DIRECTOR 1.00 X 0 0 0 JONATHAN MISSNER DIRECTOR 1.00 X 0 0 0 BRIAN ABRAHAMS CHIEF EXECUTIVE DIRECTOR 40.00 X 263040 0 31545 MOLLY SOBOROFF REGIONAL DIRECTOR 40.00 X 211889 0 17599 SHERI ZVI CHIEF DEVELOPMENT OFFICER 40.00 X 226290 0 23547 JESSICA ROZENTAL REGIONAL DIRECTOR 40.00 X 158040 0 16013 ALISA LYCHEVA FINANCE DIRECTOR 40.00 X 103659 0 3519 962918 0 92223 5 0 1 0 MILLWORK STRATEGIES 6907 WAYNE AVE PHILADELPHIA PA 19119 CONSULTING SERVICES 151000 1 1034290 26636887 27671177 1204 1204 0 1034290 561285 -561285 -561285 INSURANCE PROCEEDS 900099 200000 200000 200000 27311096 0 0 -360081 566188 566188 385358 385358 18285037 18285037 294585 97213 85430 111942 1196898 394977 347100 454821 33710 11124 9776 12810 54970 18140 15941 20889 96538 31858 27996 36684 140871 140871 191656 191656 452030 2677 211796 237557 226703 152771 31749 42183 71837 20084 31458 20295 76094 19372 18170 38552 31430 10372 9115 11943 81633 4367 5392 71874 2048 2048 34263 11307 9936 13020 22221849 20010845 1138434 1072570 3616405 1687545 9376726 14982824 35165 42670 40346 30536 4472 9810 57817 51680 0 106716 13090585 16881245 2219528 788332 25000 0 108800 2219528 922132 X 1953037 833716 8918020 15125397 10871057 15959113 13090585 16881245 X 5089247 -1191 X 0 1 X 1 0 X 3807918 7924535 3942307 10942464 27671177 54288401 3807918 7924535 3942307 10942464 27671177 54288401 25275016 29013385 1330 1124 463 2353 1204 6474 54294875 0.53440 0.53880 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 40346 30536 9810 9810 OPERATING LEASE LIABILITIES 108800 108800 X 27872381 561285 561285 27311096 0 27311096 22783134 561285 561285 22221849 0 22221849 PART X, LINE 2: AFSMC IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, AND IS EXEMPT FROM CALIFORNIA FRANCHISE TAXES UNDER SECTION 23701(D) OF THE STATE REVENUE AND TAXATION CODE. AFSMC FILES INTERNAL REVENUE SERVICE FORM 990 AND REQUIRED STATE FORMS 199 AND RRF-1. ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. AFSMC RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT OF AFSMC DOES NOT BELIEVE THE FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF DIRECT BENEFITS TO DONORS 561,285. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF DIRECT BENEFITS TO DONORS 561,285. 0 0 0 0 0 0 0 0 0 ISREAL MEDICAL RESEARCH, PANCREATIC CANCER CENTER, PEDIATRIC BURN CENTER 18285037 WIRE TRANSFER 0 1 0 0 0 0 0 0 PART III ACCOUNTING METHOD: PART II, COLUMN (D): REGION: ISRAEL (D) PURPOSE OF GRANT: MEDICAL RESEARCH, PANCREATIC CANCER CENTER, PEDIATRIC BURN CENTER, PEDIATRIC NEURO-ONCOLOGY, NEONATOLOGY, AND OTHER HOSPITAL EQUIPMENT WOA 408707 408707 137450 SALUTE TO SHEBA 274970 274970 207832 11 350613 350613 216003 1034290 1034290 561285 561285 -561285 1 MITZHAV FOR UKRAINE INC 7308 18TH AVENUE BROOKLYN NY 11204 822992136 60000 0 TRUCK TRAILER PURCHASE LIBERTY SCIENCE CENTER 222 JERSEY CITY BLVD JERSEY CITY NJ 07305 222302253 500000 0 COLLABORATION AGREEMENT CHARITABLE FUND KVITNAH 9465 WILSHIRE BLVD LOS ANGELES CA 90212 6188 0 CHARITABLE EXPENSES 3 FELLOWSHIP GRANTS 2 360000 SCULPTURE 1 9928 PARSIS SHADKAMIAN TREATMENT FUND 1 15430 PART 1, LINE 2. THE ORGANIZATION DETERMINES ELIGIBILITY BASED ON PURPOSE OF GRANT AND RECIPIENT'S PROGRAM SERVICE HISTORY. X X 0 0 0 0 0 0 0 0 0 BRIAN ABRAHAMS CHIEF EXECUTIVE DIRECTOR 262500 0 0 0 540 0 10500 0 21045 0 294585 0 0 0 SHERI ZVI CHIEF DEVELOPMENT OFFICER 225750 0 0 0 540 0 9030 0 14517 0 249837 0 0 0 MOLLY SOBOROFF REGIONAL DIRECTOR 211619 0 0 0 270 0 8465 0 9134 0 229488 0 0 0 JESSICA ROZENTAL REGIONAL DIRECTOR 157500 0 0 0 540 0 4725 0 11288 0 174053 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE TREASURER AND BOARD MEMBERS REVIEW THE RETURN BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MONITORS ITS CONFLICT OF INTEREST POLICIES. ANY OUTSIDE CONTRACTS FOR GOODS OR SERVICES ARE SUBJECT TO A BIDDING PROCESS WITH OTHER COMPANIES. A DIRECTOR WITH A CONFLICT IS REQUIRED TO RECUSE HIMSELF/HERSELF FROM THE AWARD PROCESS. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTOR'S SALRY IS REVIEWED ANNUALLY AND APPROVED BY THE EXCECUTIVE COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: IMPLEMENTATION OF FASB ASC 842, LEASES -1,191.